BRAIN CANCER

HER2-Positive Breast Cancer

BREAST CANCER

Bladder Cancer

Prostate Cancer

Renal Cell Carcinoma

GENITOURINARY CANCERS

Liquid Biopsies

GENOMIC TESTING

Colorectal Cancer

GASTRIC CANCER

GIST

GI CANCERS

Cervical Cancer

ENDOMETRIAL CANCER

Ovarian Cancer

GYNECOLOGIC CANCERS

HEAD & NECK CANCERS

BONE MARROW & STEM CELL TRANSPLANT

HEMATOLOGY

CAR T-CELL THERAPY

IMMUNOTHERAPY

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

LEUKEMIAS

MET-TARGETED THERAPY

SMALL CELL LUNG CANCER

BIOMARKER-DRIVEN LUNG CANCER

EGFR+ Lung Cancer

LUNG CANCER

DLBCL

Follicular Lymphoma

Mantle Cell Lymphoma

LYMPHOMAS

MPNs

Multiple Myeloma

NTRK GENE FUSIONS

SARCOMA

Melanoma

SKIN CANCERS

THYROID CANCERS

NEWS

All News

FDA Briefs

Oncology Icons

Special Reports

Voices from the Field

CONFERENCES

Conference Coverage

Conference Listing

MEDIA

All Videos

Case-Based Peer Perspectives

Expert Perspective Virtual Tumor Board

Interviews

Investigator Perspectives

Medical World News

Pivotal Practice Views with the Oncology Brothers

Podcasts

Precision Medicine

PUBLICATIONS

All Publications

Evolving Paradigms

Roundtable Meetings Spotlight

Targeted Therapies in Oncology

CME/CE

RESOURCES

Case-Based Roundtable Series

Clinical Trials

Partners

Precision Medicine Perspectives

Press Releases

Treatment Resources

SUBSCRIBE

eNewsletter

Print Subscription

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

About Us

Advertise

Contact Us

CureToday.com

CancerNetwork.com

OncLive.com

OncNursingNews.com

Do Not Sell My Information

Privacy

Terms & Conditions

Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Facebook

Linkedin

Twitter

YouTube

Instagram

Featured Clinical Focus

BTK Inhibitors: In-Focus

Biomarker-Driven Lung Cancer

Bone Marrow & SCT

CAR T-Cell Therapy

EGFR-Positive Lung Cancer

Endometrial Cancer

Lung Cancer

Small Cell Lung Cancer

Thyroid Cancers

Clinical Focus

Brain Cancer

Breast Cancer

Gastrointestinal Cancer

Genitourinary Cancers

Gynecologic Cancers

Head & Neck Cancers

Hematology

Leukemias

Lymphomas

Sarcoma

Skin Cancers

Spotlight

Case Based Peer Perspectives


Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.

1rem

Expert oncologist Kevin Kalinsky, MD, centers discussion on a patient case of HR+/HER2-low metastatic breast cancer to highlight current treatment options and best practices.

Case-Based Peer Perspectives: A 65-Year-Old Woman with Metastatic Breast Cancer

Videos

Expert oncologist Kevin Kalinsky, MD, reviews the diagnosis and management of a 65-year old woman with HR+/HER2-low metastatic breast cancer.

Case Overview: A 65-Year-Old Woman With HR+/HER2-low Metastatic Breast Cancer 

Comprehensive insight to the treatment armamentarium for patients with HR+/HER2-low metastatic breast cancer and factors that help inform optimal sequencing.

HR+/HER2-low Metastatic Breast Cancer: An Evolving Treatment Armamentarium 

Closing out his review of HR+/HER2-low metastatic breast cancer management, Kevin Kalinsky, MD, considers unmet needs and ongoing investigation into novel treatment strategies. 

Unmet Needs and Future Directions in HR+/HER2-low Metastatic Breast Cancer